Angiocrine Bioscience
Launch date
Employees
Market cap
-
Enterprise valuation
€211—317m (Dealroom.co estimates Oct 2021.)
New York City New York (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $4.0m | Early VC | |
| N/A | $58.1m | Early VC | |
* | $15.0m | Grant | |
| Total Funding | €70.1m | ||
Related Content
Recent News about Angiocrine Bioscience
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.